"A class of medications long used to curb HIV infection shows promise as a therapy for age-related macular degeneration (AMD), suggest findings from an NIH-funded study. These mainstay HIV drugs, called nucleoside reverse transcriptase inhibitors "...
VIGAMOX® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
Streptococcus viridans group
Haemophilus parainfluenzae *
*Efficacy for this organism was studied in fewer than 10 infections.
Dosage Forms and Strengths
4 mL bottle filled with 3 mL sterile ophthalmic solution of moxifloxacin hydrochloride, 0.5% as base.
VIGAMOX® solution is supplied as a sterile ophthalmic solution in Alcon's DROP-TAINER® dispensing system consisting of a natural low density polyethylene bottle and dispensing plug and tan polypropylene closure. Tamper evidence is provided with a shrink band around the closure and neck area of the package.
3 mL in a 4 mL bottle - NDC 0065-4013-03
Storage: Store at 2°C- 25°C (36°F - 77°F).
Manufactured by Alcon Laboratories, Inc. Fort Worth, TX 76134 USA. Licensed to Alcon, Inc. by Bayer Schering Pharma AG.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 10/24/2011
Additional Vigamox Information
Vigamox - User Reviews
Vigamox User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Get breaking medical news.